http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-99696-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
| filingDate | 1995-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4611674d796a125bb723aede6dbb873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4060989e7c24c342cf11b05a0179b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e1fbed055f1abb51c345964bceec2b |
| publicationDate | 1996-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-99696-A |
| titleOfInvention | Derivatives of 1,4-benzodiazepine, their preparation methods, containing pharmaceutical formulations, their use as sca |
| abstract | The invention relates to compounds of the general formula wherein R 1 represents CH 2 CONR 5 R 6 or CH 2 COR 7; R2 is a phenyl group optionally substituted with 1 to 2 substituents selected from the group consisting of halogen, alkyl, nitro, cyano, trifluoromethyl, trifluoromethoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, amino, substituted amino, hydroxy, alkoxy, methylenedioxy, alkoxycarbonyl, oxazolyl or oxadiazolyl; A represents a C1-4 linear or branched alkylene chain; R 3 and R 4 are independently hydrogen or C 1-4 -alkyl or R 3 and R 4 together with the nitrogen atom to which they are attached form a saturated 5- to 7-membered heterocyclic ring which ring may contain an additional heteroatom from the group of oxygen , sulfur or nitrogen; R5 is hydrogen or C1-4-alkyl; R6 is C1-4-alkyl or phenyl optionally substituted by halogen or R5 and R6 together with the nitrogen atom to which they are attached represent a saturated 5- to 7-membered heterocyclic ring which may be optionally substituted by 1 or 2 methyl groups or be joined to a benzene ring; R7 is a group selected from C1-4-alkyl or optionally substituted phenyl; R8 is hydrogen or a halogen atom and n is 0, 1 or 2 and to their physiologically acceptable salts. |
| priorityDate | 1992-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.